Market Overview The injection pen market is transforming autoimmune disease management as biologic therapies for rheumatoid arthritis, psoriasis, Crohn's disease, and multiple sclerosis transition from infusion centers to home-based subcutaneous administration. Patient self-injection pens for tumor necrosis factor inhibitors, interleukin blockers, and monoclonal antibodies reduce healthcare...